FDA investigates diabetes drug metformin for NDMA carcinogen

FDA investigates diabetes drug metformin for NDMA carcinogen
Reuters: Health
The U.S. Food and Drug Administration said on Thursday it was investigating whether metformin diabetes medicines sold in the United States contain unsafe levels of a carcinogen called NDMA.


No comments:

Post a Comment